Ofatumumab for rheumatoid arthritis

Vidhu Anand; Sushil K. Garg; Maria Angeles Lopez-Olivo; Jasvinder A. Singh

doi:10.1002/14651858.CD010833

Ofatumumab for rheumatoid arthritis

Vidhu Anand, Sushil K. Garg, Maria Angeles Lopez-Olivo, Jasvinder A. Singh

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of ofatumumab in reducing disease activity, pain, and improving function in people with RA.

Original language	English (US)
Article number	CD010833
Journal	Cochrane Database of Systematic Reviews
Volume	2013
Issue number	11
DOIs	https://doi.org/10.1002/14651858.CD010833
State	Published - Nov 17 2013
Externally published	Yes

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD010833

Cite this

@article{f9d46d2779e34d0195ce904efafb2f1d,

title = "Ofatumumab for rheumatoid arthritis",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of ofatumumab in reducing disease activity, pain, and improving function in people with RA.",

author = "Vidhu Anand and Garg, {Sushil K.} and Lopez-Olivo, {Maria Angeles} and Singh, {Jasvinder A.}",

note = "Publisher Copyright: {\textcopyright} 2013 The Cochrane Collaboration.",

year = "2013",

month = nov,

day = "17",

doi = "10.1002/14651858.CD010833",

language = "English (US)",

volume = "2013",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Ofatumumab for rheumatoid arthritis

AU - Anand, Vidhu

AU - Garg, Sushil K.

AU - Lopez-Olivo, Maria Angeles

AU - Singh, Jasvinder A.

PY - 2013/11/17

Y1 - 2013/11/17

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of ofatumumab in reducing disease activity, pain, and improving function in people with RA.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of ofatumumab in reducing disease activity, pain, and improving function in people with RA.

UR - http://www.scopus.com/inward/record.url?scp=85041710008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041710008&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD010833

DO - 10.1002/14651858.CD010833

M3 - Article

AN - SCOPUS:85041710008

SN - 1361-6137

VL - 2013

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD010833

ER -

Ofatumumab for rheumatoid arthritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this